Analysis of first-line treatment in older patients with metastasic colorectal cancer.
Arantxa Magallón MartínezMaria J Agustín FerrándezAndrea Pinilla RelloVicente Gimeno-BallesterAngel Escolano PueyoOlga Pereira BlancoSara MaloMaria R Abad SazatornilPublished in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2021)
Our patients presented baseline clinical characteristics similar to the general adult population, with no tumour characteristics associated with advanced age. The efficacy and toxicity were similar to those in the clinical trials, although our patients had more dose reductions. Considering the heterogeneity of patients and in the absence of clinical trials in the older population, real-life studies can be very useful.